Literature DB >> 22949510

Mutant Twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression.

Lanying Song1, Yuxi Shan, K C Kent Lloyd, Gino A Cortopassi.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder in the developed world, and is characterized by the loss of dopaminergic (DA) neurons in the substantia nigra (SN). Somatic mitochondrial DNA (mtDNA) deletions reach their highest concentration with age in the SN in humans, and may contribute to PD; yet whether mtDNA deletions cause DA neuron degeneration remains unclear. Inherited mutations of Twinkle helicase involved in mtDNA replication causes a dominant increase in mtDNA deletions in humans. We constructed a mouse model expressing mutant Twinkle in DA neurons. Mutant mice had an increase in age-related mtDNA deletions, reduction of DA neuron number in SN at 17-22 months and displayed abnormalities in rota-rod behavior. Functional analysis of midbrain indicated a slight reduction in mitochondrial state II respiration in mutants, but no decrease in maximal respiration. Also, Parkin expression was significantly decreased in DA neurons in the SN of 22-month-old mutant mice, and in PC12 cells after 48 h transfection of mutant Twinkle. Both confocal imaging and coimmunoprecipitation indicated interaction of Twinkle with Parkin in the mitochondria. Parkin overexpression rescued the reduction of proteasome activity caused by mutant Twinkle in PC12 cells. In addition, the autophagy marker LC3 was increased in the SN of 22-month transgenics, and this increase was similarly mutant Twinkle-dependent in PC12 cells. Collectively, our data demonstrate that mammalian Twinkle is important for mitochondrial integrity in DA neurons and provide a novel mouse model in which increased mtDNA deletions may lead to DA neuron degeneration and parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949510      PMCID: PMC3607469          DOI: 10.1093/hmg/dds365

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

1.  Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons.

Authors:  Hirokazu Fukui; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2008-12-18       Impact factor: 6.150

2.  Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma.

Authors:  Crystal R Archer; Dana-Lynn T Koomoa; Erin M Mitsunaga; Jérôme Clerc; Mariko Shimizu; Markus Kaiser; Barbara Schellenberg; Robert Dudler; André S Bachmann
Journal:  Biochem Pharmacol       Date:  2010-04-01       Impact factor: 5.858

3.  Parkin directly modulates 26S proteasome activity.

Authors:  Ji Won Um; Eunju Im; Hyun Jung Lee; Boram Min; Lang Yoo; Jiho Yoo; Hermann Lübbert; Christine Stichel-Gunkel; Hyun-Soo Cho; Jong Bok Yoon; Kwang Chul Chung
Journal:  J Neurosci       Date:  2010-09-01       Impact factor: 6.167

4.  Astrocytic activation and an inhibition of MAP kinases are required for proteinase-activated receptor-2-mediated protection from neurotoxicity.

Authors:  Sam M Greenwood; Trevor J Bushell
Journal:  J Neurochem       Date:  2010-04-06       Impact factor: 5.372

5.  Oligodendroglial differentiation induces mitochondrial genes and inhibition of mitochondrial function represses oligodendroglial differentiation.

Authors:  Robert Schoenfeld; Alice Wong; Jillian Silva; Ming Li; Aki Itoh; Makoto Horiuchi; Takayuki Itoh; David Pleasure; Gino Cortopassi
Journal:  Mitochondrion       Date:  2009-12-22       Impact factor: 4.160

6.  Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy.

Authors:  Joo-Yong Lee; Yoshito Nagano; J Paul Taylor; Kah Leong Lim; Tso-Pang Yao
Journal:  J Cell Biol       Date:  2010-05-10       Impact factor: 10.539

7.  Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair.

Authors:  Oliver Rothfuss; Heike Fischer; Takafumi Hasegawa; Martina Maisel; Petra Leitner; Franziska Miesel; Manu Sharma; Antje Bornemann; Daniela Berg; Thomas Gasser; Nadja Patenge
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

8.  Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.

Authors:  Clement A Gautier; Tohru Kitada; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

9.  Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis.

Authors:  Maria J Casarejos; Rosa M Solano; José A Rodriguez-Navarro; Ana Gómez; Juan Perucho; Jose G Castaño; Justo García de Yébenes; Maria A Mena
Journal:  J Neurochem       Date:  2009-06-22       Impact factor: 5.372

Review 10.  The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.

Authors:  Tianhong Pan; Seiji Kondo; Weidong Le; Joseph Jankovic
Journal:  Brain       Date:  2008-01-10       Impact factor: 13.501

View more
  15 in total

1.  Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage.

Authors:  Murat F Gorgun; Ming Zhuo; Ella W Englander
Journal:  Mol Neurobiol       Date:  2016-11-17       Impact factor: 5.590

Review 2.  Mitochondrial genome changes and neurodegenerative diseases.

Authors:  Milena Pinto; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2013-11-16

Review 3.  Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.

Authors:  Luisa Iommarini; Susana Peralta; Alessandra Torraco; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-01-29       Impact factor: 4.160

Review 4.  Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases.

Authors:  Karen L DeBalsi; Kirsten E Hoff; William C Copeland
Journal:  Ageing Res Rev       Date:  2016-04-30       Impact factor: 10.895

Review 5.  Parkinson's disease: experimental models and reality.

Authors:  Peizhou Jiang; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2017-11-18       Impact factor: 17.088

Review 6.  Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

Authors:  Amy Reeve; Eve Simcox; Doug Turnbull
Journal:  Ageing Res Rev       Date:  2014-02-03       Impact factor: 10.895

7.  Oxidative Insults and Mitochondrial DNA Mutation Promote Enhanced Autophagy and Mitophagy Compromising Cell Viability in Pluripotent Cell Model of Mitochondrial Disease.

Authors:  Dar-Shong Lin; Yu-Wen Huang; Che-Sheng Ho; Pi-Lien Hung; Mei-Hsin Hsu; Tuan-Jen Wang; Tsu-Yen Wu; Tsung-Han Lee; Zo-Darr Huang; Po-Chun Chang; Ming-Fu Chiang
Journal:  Cells       Date:  2019-01-17       Impact factor: 6.600

8.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

Review 9.  Brain Mitochondria, Aging, and Parkinson's Disease.

Authors:  Mario Rango; Nereo Bresolin
Journal:  Genes (Basel)       Date:  2018-05-11       Impact factor: 4.096

10.  Twinkle-associated familial parkinsonism with Lewy pathology: Cause or predisposition?

Authors:  David P Breen; David G Munoz; Anthony E Lang
Journal:  Neurology       Date:  2020-08-26       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.